Biotech3 hours ago
Eli Lilly Enters Recombinase Gene Editing Through Strategic German Partnership
Eli Lilly has partnered with Dresden-based Seamless Therapeutics to develop a recombinase-based gene therapy for genetically caused hearing loss. Seamless will engineer precise recombinases, while Lilly...